Andreas Højlund

Dr. Andreas Højlund

Center of Functionally Integrative Neuroscience, Aarhus University, Aarhus, Denmark
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2010 in Learning and Individual Differences
Verified
Journal Article
Closed access
MWMikkel Wallentin
Mikkel Wallentin
AHAndreas Højlund
Andreas Højlund
MFMorten Friis-Olivarius
Morten Friis-Olivarius
CVChristian Vuust
Christian Vuust
PVPeter Vuust
Peter Vuust

1 October 2011 in NeuroImage
Verified
Journal Article
Closed access
MWMikkel Wallentin
Mikkel Wallentin
AHAndreas Højlund
Andreas Højlund
PVPeter Vuust
Peter Vuust
ADAnders Dohn
Anders Dohn
ARAndreas Roepstorff
Andreas Roepstorff
TLTorben Ellegaard Lund
Torben Ellegaard Lund

1 December 2011 in Brain and Language
Verified
Journal Article
Closed access
MWMikkel Wallentin
Mikkel Wallentin
AHAndreas Højlund
Andreas Højlund
PVPeter Vuust
Peter Vuust
ADAnders Dohn
Anders Dohn
ARAndreas Roepstorff
Andreas Roepstorff
TLTorben Ellegaard Lund
Torben Ellegaard Lund

17 February 2023 in Journal of Neurology, Neurosurgery & Psychiatry
Verified
Journal Article
Closed access
PDF file
JAJordan N Alves
Jordan N Alves
BWBritta U Westner
Britta U Westner
AHAndreas Højlund
Andreas Højlund
RWRimona S. Weil
Rimona S. Weil
SDSarang S Dalal
Sarang S Dalal
Parkinson’s disease is caused by degeneration of dopaminergic neurons, originating in thesubstantia nigra pars compactaand characterised by bradykinesia, rest tremor and rigidity. In addition, visual disorders and retinal abnormalities are often present and can be identified by decreased visual acuity, abnormal spatial contrast sensitivity or even difficulty in complex visual task completion. Because of their early onset in patients with de novo Parkinson’s disease, the anatomical retinal changes and electrophysiological modification could be valuable markers even at early stages of the disease. However, due to the concomitant occurrence of normal ageing, the relevance and specificity of these predictive values can be difficult to interpret. This review examines retinal dysfunction arising in Parkinson’s disease. We highlight the electrophysiological delays and decreased amplitude in the electroretinography recorded in patients and animal models. We relate this to coexisting anatomical changes such as retinal nerve fibre layer and macular thinning, measured using optical coherence tomography, and show that functional measures are more consistent overall than optical coherence-measured structural changes. We review the underlying chemical changes seen with loss of retinal dopaminergic neurons and the effect of levodopa treatment on the retina in Parkinson’s disease. Finally, we consider whether retinal abnormalities in Parkinson’s disease could have a role as potential markers of poorer outcomes and help stratify patients at early stages of the disease. We emphasise that retinal measures can be valuable, accessible and cost-effective methods in the early evaluation of Parkinson’s disease pathogenesis with potential for patient stratification.

1 November 2019 in Cortex
Verified
Journal Article
Closed access
DQDavid R. Quiroga-Martinez
David R. Quiroga-Martinez
NHNiels C. Hansen
Niels C. Hansen
AHAndreas Højlund
Andreas Højlund
MPMarcus T. Pearce
Marcus T. Pearce
EBElvira Brattico
Elvira Brattico
PVPeter Vuust
Peter Vuust

10 December 2016 in Computational and Structural Biotechnology Journal
Verified
Journal Article
Open access
AHAndreas Højlund
Andreas Højlund
MPMikkel V. Petersen
Mikkel V. Petersen
KSKousik Sarathy Sridharan
Kousik Sarathy Sridharan
KØKaren Østergaard
Karen Østergaard
Worsening of verbal fluency after treatment with deep brain stimulation in Parkinson's disease patients is one of the most often reported cognitive adverse effect. The underlying mechanisms of this decline are not well understood. The present focused review assesses the evidence for the reliability of the often-reported decline of verbal fluency, as well as the evidence for the suggested mechanisms including disease progression, reduced medication levels, electrode positions, and stimulation effect vs. surgical effects. Finally, we highlight the need for more systematic investigations of the large degree of heterogeneity in the prevalence of verbal fluency worsening after DBS, as well as provide suggestions for future research.